Home
Scholarly Works
Stereotactic Ablative Radiotherapy (SABR) in...
Journal article

Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic and Oligoprogressive Gynecologic Cancers: Clinical Outcomes of a Single Institution Analysis

Authors

Donovan E; Cheung P; Erler D; Davidson MTM; Sahgal A; Chung HT; Poon I; Taggar A; Barnes E; Jerzak K

Journal

International Journal of Radiation Oncology • Biology • Physics, Vol. 108, No. 3, pp. e179–e180

Publisher

Elsevier

Publication Date

November 1, 2020

DOI

10.1016/j.ijrobp.2020.07.1389

ISSN

0360-3016

Contact the Experts team